COVID-19: Clinical, Immunological, and Image Findings from Infection to Post-COVID Syndrome
- Authors: Georon Ferreira de Sousa1, Guilherme Antonio de Souza Silva2, Bárbara Rafaela da Silva Barros3, Rodrigo Cesar Abreu de Aquino4, Maríllia Raphaella Cabral Fonseca de Lima5, Leonardo Carvalho de Oliveira Cruz6, Elifrances Galdino de Oliveira7, Igor Wesland Assunção de Sá8, Fábio Augusto da Cunha Rodrigues9, Francisco Hélio Oliveira10, Antonio Carlos de Freitas11, Evônio de Barros Campelo Júnior12, Cristiane Moutinho Lagos de Melo13
-
View Affiliations Hide AffiliationsAffiliations: 1 Laboratory of Immunological and Antitumor Analysis, Department of Antibiotics, BioscienceCenter, Federal University of Pernambuco, Brazil 2 Laboratory of Immunological and Antitumor Analysis, Department of Antibiotics, BioscienceCenter, Federal University of Pernambuco, Brazil 3 Laboratory of Immunological and Antitumor Analysis, Department of Antibiotics, BioscienceCenter, Federal University of Pernambuco, Brazil 4 Laboratory of Immunological and Antitumor Analysis, Department of Antibiotics, BioscienceCenter, Federal University of Pernambuco, Brazil 5 Laboratory of Immunological and Antitumor Analysis, Department of Antibiotics, BioscienceCenter, Federal University of Pernambuco, Brazil 6 Laboratory of Immunological and Antitumor Analysis, Department of Antibiotics, BioscienceCenter, Federal University of Pernambuco, Brazil 7 Laboratory of Neuroendocrinology and Metabolism, Department of Physiology andPharmacology, Center for Biosciences, Federal University of Pernambuco, Brazil 8 Clinics Hospital of Federal University of Pernambuco, Brazil 9 Clinics Hospital of Federal University of Pernambuco, Brazil 10 Clinics Hospital of Federal University of Pernambuco, Brazil 11 Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, BioscienceCenter, Federal University of Pernambuco, Brazil 12 Clinics Hospital of Federal University of Pernambuco, Brazil 13 Laboratory of Immunological and Antitumor Analysis, Department of Antibiotics, BioscienceCenter, Federal University of Pernambuco, Brazil
- Source: Intelligent Diagnosis of Lung Cancer and Respiratory Diseases , pp 76-98
- Publication Date: July 2022
- Language: English
The SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is a virus responsible for the COVID-19 pandemic outbreak. The virus has high infectious power and easy ability to spread geographically, due to the fact that the infection is asymptomatic in some cases. However, 25% of patients infected by SARS-CoV-2 can progress to the severity of the disease and develop acute respiratory distress syndrome (ARDS). The symptoms are commonly recognized as fever, dry cough, tachypnea, shortness of breath, sore throat, sneezing, nasal congestion, and other symptoms, including severe inflammatory responses with the evolution of cytokine storm, pneumonia, and sepsis. Here, we show the COVID-19 since infection in the host cell to Post-COVID-19 syndrome, relating the occurrence of virus variants, laboratory and immunological aspects, the major clinical manifestations and image findings, and all aspects associated with pulmonary damage promoted by the virus.
-
From This Site
/content/books/9789815050509.chap4dcterms_subject,pub_keyword-contentType:Journal105
